Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRemoved the Genetic and Rare Diseases Information Center from Resources and removed the Interstitial lung disease 2 tag.SummaryDifference0.1%

- Check15 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; the update is visible in the footer and does not alter study details or page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check51 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; this is a minor technical update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page shows a minor revision tag updated from v3.4.0 to v3.4.1, likely in the footer. This change does not alter study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, indicating a minor site update or bug fix with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.